Moderna Stock

Moderna EPS

The Earnings per Share (EPS) of Moderna (MRNA) as of Aug 3, 2026 is -7.20 USD. In the previous year, Earnings per Share (EPS) was -9.25 USD — a change of -22.17% (higher).

EPS

-7.20USD

YoY

-22.17%

Last updated:

Earnings per Share (EPS) of Moderna is 2026 -7.20 USD. Earnings per Share (EPS) of Moderna was 2025 -9.25 USD. It decreases by -22.17% higher compared to the previous year.
Access this data via the Eulerpool API

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

Earnings per Share (EPS) of Moderna is -7.20 USD in 2026.

Earnings per Share (EPS) of Moderna changed from -9.25 USD to -7.20 USD, representing a -22.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Moderna since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Moderna

All Key Metrics — Moderna